Net Clinical Benefit of Oral Anticoagulants: A Multiple Criteria Decision Analysis

BACKGROUND: This study quantitatively evaluated the comparative efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, and apizaban) and warfarin for treatment of nonvalvular atrial fibrillation. We also compared these agents under different scenarios, including population with hig...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Jason C., Hsieh, Cheng-Yang, Yang, Yea-Huei Kao, Lu, Christine Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4405347/
https://www.ncbi.nlm.nih.gov/pubmed/25897861
http://dx.doi.org/10.1371/journal.pone.0124806

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4405347/
https://www.ncbi.nlm.nih.gov/pubmed/25897861
http://dx.doi.org/10.1371/journal.pone.0124806

Ejemplares similares